Biohybrid nanorobots induce lactate isomer conversion to reverse the immune environment and promote tumor therapy
Science Advances · 14.11.2025 · 11 (46)
DOI: 10.1126/sciadv.adz8419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 14.11.2025. Verfasst von Yueyue Fan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Lactic Acid, Metal Nanoparticles, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Natural Science Funds for Excellent Young Scholars, Emerging Frontiers Cultivation Program of Tianjin University Interdisciplinary Center.
Abstract (Originalsprache)
Tumor cell glycolysis produces high levels of l -lactate ( l -LA), creating an immunosuppressive microenvironment that enhances tumor stemness and impairs the efficacy of cancer therapies. Current strategies to reduce l -LA are limited by physical barriers in solid tumors and resource waste. This study presents an intelligent nanorobot that not only enhances tumor targeting and deep penetration but also reprograms the tumor immune microenvironment to convert l -LA into immunostimulatory d -lactate ( d -LA). The nanorobot uses gold nanoparticles to bridge palladium (Pd) nanozymes and Lactobacillus crispatus –derived outer membrane vesicles (CMVs). Pd nanozymes catalyze H 2 O 2 into O 2 , facilitating deep tumor penetration, whereas the acidic tumor microenvironment activates Pd nanozymes to produce hydroxyl radicals (·OH), inducing immunogenic cell death. CMVs, which are rich in d -lactate dehydrogenase and artificially introduce lactate oxidase, catalyze the conversion of l -LA to d -LA, reversing its immunosuppressive effects. Preclinical models demonstrate potent antitumor effects, enhancing the immune response and reshaping the tumor microbiome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.
- Gynecology and Oncology Department, Jiaozuo Second People's Hospital, The First Affiliated Hospital of Henan University of Technology, Jiaozuo 454000, Henan, China.
- Department of General Surgery, First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
ORCID-Profile: Yueyue Fan, Jiamin Ye, Jiacheng Shi, Li Wang, Yong Kang, Xiaoyuan Ji
Förderung
- National Natural Science Foundation of China
- National Natural Science Funds for Excellent Young Scholars
- Emerging Frontiers Cultivation Program of Tianjin University Interdisciplinary Center
Zitieren
APA
Fan, Y., Ye, J., Niu, G., She, Y., Li, R., Shi, J., Yang, Y., Wang, L., Kang, Y., & Ji, X. (2025). Biohybrid nanorobots induce lactate isomer conversion to reverse the immune environment and promote tumor therapy. Science Advances, 11(46). https://doi.org/10.1126/sciadv.adz8419
Vancouver
Fan Y, Ye J, Niu G, She Y, Li R, Shi J, et al. Biohybrid nanorobots induce lactate isomer conversion to reverse the immune environment and promote tumor therapy. Science Advances. 2025;11(46). doi:10.1126/sciadv.adz8419
BibTeX
@article{Fan2025,
author = {Fan, Yueyue and Ye, Jiamin and Niu, Gaoli and She, Yaoguang and Li, Ruiyan and Shi, Jiacheng and Yang, Yiwen and Wang, Li and Kang, Yong and Ji, Xiaoyuan},
title = {Biohybrid nanorobots induce lactate isomer conversion to reverse the immune environment and promote tumor therapy},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {46},
doi = {10.1126/sciadv.adz8419}
}
EUVIMED